What is the recommended STI screening assessment and management plan?

STI Screening Assessment and Management Plan

All sexually active individuals under age 30 should receive annual screening for chlamydia and gonorrhea, with more frequent screening (every 3-6 months) for high-risk populations including men who have sex with men (MSM), those with multiple partners, and individuals in high-prevalence communities 1, 2, 3.

Risk-Stratified Screening Approach

Universal Annual Screening (All Sexually Active Patients)

Women ≤25 years:

• Screen for chlamydia and gonorrhea annually 1, 2
• Test urine or vaginal swab specimens
• Screen regardless of symptoms

Men <30 years:

• Consider annual screening based on local prevalence and individual risk factors 2, 3
• Urine testing for urethral infections
• Contact local health department for community prevalence data to guide decisions 2

Intensified Screening (Every 3-6 Months)

Men who have sex with men:

• Screen at all anatomic sites of exposure 2:
  • Pharyngeal swab if receptive oral intercourse
  • Rectal swab if receptive anal intercourse
  • Urethral/urine if insertive intercourse
• Screen every 3-6 months if high-risk behaviors (multiple/anonymous partners, drug use during sex) 2
• Include syphilis screening annually or every 3-6 months if high-risk 2

Other high-risk populations requiring frequent screening:

• Multiple sexual partners or new partner since last test 3
• History of prior STIs 2
• Sex work or exchange of sex for payment 2
• Injection drug use 2
• High-prevalence communities (consider "opt-out" screening every 3 months) 3

Essential Assessment Components

Sexual history must include:

• Number and gender of sexual partners (ask about same-sex partners regardless of stated orientation) 2
• Types of sexual contact: vaginal, oral, anal 2
• New partners since last testing
• Partner STI history or symptoms
• Condom use patterns
• Drug use associated with sex

This history directly determines which anatomic sites to test - a critical point often missed in practice 2.

Selective Screening Recommendations

Syphilis:

• NOT routinely recommended for heterosexual adolescents/adults 2
• Screen all sexually active MSM annually or every 3-6 months if high-risk 2
• Screen pregnant women
• Screen based on local prevalence and individual risk factors 2

Trichomoniasis:

• NOT routinely recommended for asymptomatic patients 2
• Consider for high-risk women (multiple partners, prior STI history, sex work, injection drug use) 2

HIV:

• Screen all sexually active adolescents and adults at least once 2
• More frequent screening for high-risk populations

Post-Treatment Management

Mandatory rescreening at 3 months after treatment for:

• All patients treated for chlamydia 2
• All patients treated for gonorrhea 2
• Rescreen regardless of whether partners were treated 2
• If 3-month retest not possible, retest at next visit within 12 months 2

Test-of-cure required for:

• All pharyngeal gonorrhea cases 4
• Rectal chlamydia treated with azithromycin 4

Critical Practice Points

Common pitfalls to avoid:

• Screening women but not men - men are significantly undertested despite similar risk 1
• Missing extragenital sites in MSM - pharyngeal and rectal infections are frequently asymptomatic 2
• Failing to rescreen at 3 months - reinfection rates are high 2
• Not asking about same-sex partners in patients who identify as heterosexual 2

When any STI is detected:

• Screen for other STIs including HIV 2
• Provide prevention counseling and promote condom use 2
• Offer expedited partner therapy where legally permitted 2
• Report to public health authorities for partner notification 4

The evidence supporting these recommendations is rated as very low certainty 3, but the high prevalence in young adults (chlamydia affects 4.7% of women aged 18-26) 1 and potential for serious sequelae justify this screening approach in real-world practice.